🕵️ Neumora Therapeutics, Inc. ($NMRA)
SEC insider & ownership activity, last 12 months · CIK 1885522 · every row links its SEC filing
Over the last 12 months insiders sold $1.1M against $15.0M of open-market buying. Burow Kristina bought $5.0M in discretionary trades (Oct). 4 planned sales are pending, the largest $220K (Aurora Daljit Singh). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
3 buyers, $15.0M (3 lots) · 4 sellers, $1.1M (16 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Burow Kristina | 1 | $5.0M | 0 | – | Oct 27, 2025 |
| ARCH Venture Partners XII, LLC | 1 | $5.0M | 0 | – | Oct 27, 2025 |
| ARCH Venture Partners X, LLC | 1 | $5.0M | 0 | – | Oct 27, 2025 |
| Aurora Daljit Singh | 0 | – | 13 | $1.0M | Aug 21, 2026 |
| Paul L. Berns | 0 | – | 1 | $34K | Feb 17, 2026 |
| Pinto Joshua | 0 | – | 1 | $21K | Feb 17, 2026 |
| Milligan Michael Lee | 0 | – | 1 | $5K | Feb 17, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Kristina Burow | 18.7% | 13D | Mar 30, 2026 | filing ↗ | |
| Keith Crandell | 18.6% | 13D | Mar 30, 2026 | filing ↗ | |
| Robert Nelsen | 18.6% | 13D | Mar 30, 2026 | filing ↗ | |
| ARCH Venture Partners XII, LLC | 18.6% | 13D | Mar 30, 2026 | filing ↗ | |
| ARCH Venture Fund XII, L.P. | 18.6% | 13D | Mar 30, 2026 | filing ↗ | |
| ARCH Venture Partners XII, L.P. | 18.6% | 13D | Mar 30, 2026 | filing ↗ | |
| ARCH Venture Fund VII, L.P. | 18.6% | 13D | Mar 30, 2026 | filing ↗ | |
| ARCH Venture Fund VIII Overage, L.P. | 18.6% | 13D | Mar 30, 2026 | filing ↗ | |
| ARCH Venture Fund X, L.P. | 18.6% | 13D | Mar 30, 2026 | filing ↗ | |
| ARCH Venture Fund X Overage, L.P. | 18.6% | 13D | Mar 30, 2026 | filing ↗ | |
| ARCH Venture Partners VII, L.P. | 18.6% | 13D | Mar 30, 2026 | filing ↗ | |
| ARCH Venture Partners X, L.P. | 18.6% | 13D | Mar 30, 2026 | filing ↗ | |
| ARCH Venture Partners X Overage, L.P. | 18.6% | 13D | Mar 30, 2026 | filing ↗ | |
| ARCH Venture Partners VII, LLC | 18.6% | 13D | Mar 30, 2026 | filing ↗ | |
| ARCH Venture Partners VIII, LLC | 18.6% | 13D | Mar 30, 2026 | filing ↗ | |
| ARCH Venture Partners X, LLC | 18.6% | 13D | Mar 30, 2026 | filing ↗ | |
| Steven Gillis | 17.3% | 13D | Mar 30, 2026 | filing ↗ | |
| Paul L. Berns | 5.1% | 13G | Feb 13, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Aurora Daljit Singh | $66K | Aug 21, 2026 | filing ↗ |
| Aurora Daljit Singh | $204K | Aug 20, 2026 | filing ↗ |
| Aurora Daljit Singh | $102K | Aug 19, 2026 | filing ↗ |
| Aurora Daljit Singh | $110K | Aug 18, 2026 | filing ↗ |
| Aurora Daljit Singh | $220K | Aug 17, 2026 | filing ↗ |
| Pinto Joshua | $21K | Feb 17, 2026 | filing ↗ |
| Paul L. Berns | $34K | Feb 17, 2026 | filing ↗ |
| Aurora Daljit Singh | $22K | Feb 17, 2026 | filing ↗ |
| Milligan Michael Lee | $5K | Feb 17, 2026 | filing ↗ |
| Aurora Family Trust | $307K | Nov 11, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Aug 14, 2026 | filing ↗ |
| Officer/director changes (5.02) | Aug 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 14, 2026 | filing ↗ |
| Other events (8.01) | Jul 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 27, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 10, 2026 | filing ↗ |
| New financial obligation (2.03) | Jun 10, 2026 | filing ↗ |
| Exit or disposal costs (2.05) | Jun 10, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 10, 2026 | filing ↗ |
| Other events (8.01) | Jun 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 10, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 27, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Earnings (2.02) | Mar 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 30, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 11, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Other events (8.01) | Jan 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 5, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Nov 17, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 17, 2025 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |
| Other events (8.01) | Oct 27, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 27, 2025 | filing ↗ |
| Other events (8.01) | Oct 27, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 27, 2025 | filing ↗ |